GlassScriptPhysician profile
Grace E Da Cunha
NPI 1164850475
$806.06
in general payments reported to CMS, 2019-2025
11 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $207 · 2023: $104 · 2024: $197 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.73 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $162.13 | 2021-2024 | Zejula, Jemperli |
| Genmab U.S., INC. | $120.65 | 2025 | Tivdak |
| Axonics, INC. | $105.85 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2024 | Lynparza |
| Astellas Pharma US INC | $77.11 | 2022-2023 | Myrbetriq, Veozah |
| Urovant Sciences INC | $61.58 | 2021-2022 | |
| Dentsply Ih INC. | $54.93 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $53.54 | 2022-2023 | Mychoice Cdx |
| Caris Mpi, INC. | $40.86 | 2025 | Mi Cancer Seek |
| Rochester Medical Corporation | $16.25 | 2021 | |
| Merck Sharp & Dohme LLC | $13.17 | 2023 | Keytruda, Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Da Cunha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.